ReviewCurrent opinion in lipidology2026

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Katherine Muñoz Ayala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.